As costs for AOMs increase, large employers are finding ways to continue coverage
Large institutions know how effective anti-obesity medications are, but the prohibitive cost of many AOMs is forcing some to reduce or eliminate coverage. The State of Connecticut found another option: partner with Intellihealth to cover obesity treatment and medications for its employees in a cost-effective manner.
Read more at the Wall Street Journal (subscription required)
